new molecules and indications for glp 1 medicines Current Insights, Advantages Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review A glimpse of the future:

Food & Drug Administration, Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity (2024)

Both medications use the same active compound, Semaglutide

Patient preference and clinical characteristics should influence the choice of a second-line glucose-lowering medication

There's a reason people are raving about us

Market Overview Prediabetes is a metabolic condition characterized by elevated blood glucose levels that are not yet high enough to be classified as type 2 diabetes

UK Medical Evidence Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes